Successful rapid subcutaneous desensitization to anakinra in a case of delayed-type hypersensitivity reaction

Br J Dermatol. 2016 Jun;174(6):1417-8. doi: 10.1111/bjd.14454. Epub 2016 Mar 20.

Authors

V Leroy¹, E Lazaro², A-S Darrigade¹, A Taïeb^{1

3}, B Milpied¹, J Seneschal^{1

3}

Affiliations

¹ Department of Dermatology and Paediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, University of Bordeaux, 1 Rue Jean Burguet, 33075, Bordeaux CEDEX, France.
² Department of Internal Medicine, Hôpital du Haut-Lévêque, University of Bordeaux, Pessac, France.
³ INSERM U1035, University of Bordeaux, Bordeaux, France.

PMID: 26852184
DOI: 10.1111/bjd.14454

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antirheumatic Agents / administration & dosage
Antirheumatic Agents / adverse effects*
Drug Administration Schedule
Drug Eruptions / etiology*
Female
Humans
Hypersensitivity, Delayed / chemically induced*
Interleukin 1 Receptor Antagonist Protein / administration & dosage
Interleukin 1 Receptor Antagonist Protein / adverse effects*
Still's Disease, Adult-Onset / drug therapy

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein